Replies to post #90359 on Cytodyn Inc (CYDY)

[Scooter McCabe]

Let's Break This Down:

Leronlimab is the "front runner in the Covid space" where?

Current available drugs only have a 30% efficacy with safety issues. Leronlimab has a great safety record and EINDs with 80% efficacy is very promising. Against current drugs we would appear to be in the lead until further studies say otherwise.

Both tout patients Mottet and the 23 y/o girl both stated they don't know with 100% certainty if the leronlimab helped them or not.

They've stated it saved their lives. Their doctors have also stated they believe the drug to be responsible for their survival.

Fact is NOTHING has cured covid, everybody (including big pharma) trying to make a couple of dollars touting their drugs.

Covid will be like the common cold or flu- no cure.

This is fun because it relates back into the first statement made. Because a cure is unlikely our drug would be a front runner as it would be the best drug out there if approved.

Even more interesting is the bar the FDA has set for a "vaccine." The FDA has stated they only require a 50% success rate for a drug to be approved as a vaccine. So if we fall anywhere between 50 to 80% it is off to the races for CYDY.

MYTHS BUSTED.

[Fumbler]

Leronlimab blocks CCR5 receptors and enhances the body's immune system to combat illness. It's not a cure in and of itself. You need to do some research.